# Quality Gate Report

## Spec Reference
- **Spec**: `specs/001-add-cross-review-rounds-to-workflows/01-spec.md`
- **Implementation Summary**: `specs/001-add-cross-review-rounds-to-workflows/04-implementation-summary.md`
- **Test Report**: `specs/001-add-cross-review-rounds-to-workflows/04-test-report.md`

---

## Test Suite Results

### Run Command

Manual structural inspection of `workflows/patch.md`, `workflows/minor.md`, and `workflows/major.md` (no automated test runner exists for workflow markdown files).

### Results
- **Total acceptance criteria**: 10
- **Passed**: 8
- **Failed**: 2
- **All tests passing**: NO

---

## Acceptance Criteria Validation

### AC-1: Phase 4 cross-review exists in patch.md

- **Status**: FAIL
- **Evidence**: Reading `workflows/patch.md` Phase 4 (`## Phase 4: Implementation`, lines 109–138) directly:
  - Step 3: `**Launch \`software-engineer\` in IMPLEMENTATION mode**`
  - Step 4: `**After SE completes, launch \`qa-engineer\` in IMPLEMENTATION mode** (or in parallel if determined safe in step 2):`
  - Step 5: `**Read both output documents.**`
  - Step 6: `**Present results to the user**:`
  - Step 7: `**User checkpoint**:`

  There is no cross-review step between steps 4 and 5. The spec requires that after SE and QA complete their implementation work, "a parallel cross-review round where SE reads `04-test-report.md` and appends cross-review notes to `04-implementation-summary.md`, and QA reads `04-implementation-summary.md` and appends cross-review notes to `04-test-report.md`" is inserted before the results are presented. That step is entirely absent from the live file.

- **Notes**: The implementation summary (PR 2 section) and the test report both explicitly state that AC-1 was handled in a "prior session" (PR 1). However, the live file does not contain the AC-1 change. Either PR 1 was never committed to the files on disk, or the changes were not persisted. The live file is the source of truth and the criterion is not met.

---

### AC-2: Phase 4 cross-review exists in minor.md

- **Status**: FAIL
- **Evidence**: Reading `workflows/minor.md` Phase 4 (`## Phase 4: Implementation`, lines 182–236) directly:
  - Step 4: `**After all sub-PRs are implemented**:` (consolidation step)
  - Step 5: `**Read both output documents.**`
  - Step 6: `**Present results to the user**:`
  - Step 7: `**User checkpoint**:`

  There is no cross-review step between steps 4 and 5. The spec requires that after all sub-PRs are implemented, "a parallel cross-review round where SE reads `04-test-report.md` and appends cross-review notes to `04-implementation-summary.md`, and QA reads `04-implementation-summary.md` and appends cross-review notes to `04-test-report.md`" is inserted before presenting results. That step is entirely absent from the live file.

- **Notes**: The test report explicitly states "PR 1 scope items (AC-1, AC-2, and AC-9/AC-10 for patch.md Phase 4 and minor.md) are not validated in this report — they were handled in the PR 1 session." However, the live file does not contain the AC-2 change. The live file is the source of truth and the criterion is not met.

---

### AC-3: Phase 4 cross-review exists in major.md

- **Status**: PASS
- **Evidence**: Reading `workflows/major.md` Phase 4, step 5 (lines 288–300):
  ```
  5. **Cross-review round** — Launch agents in parallel (2 or 4):

     a. **`software-engineer` in IMPLEMENTATION mode (cross-review)**:
     - Prompt: "You are completing a cross-review. Read the QA Engineer's test report at `{SPEC_FOLDER}/04-test-report.md`. Then read your own implementation summary at `{SPEC_FOLDER}/04-implementation-summary.md`. Append a '## Cross-Review Notes' section to your document at `{SPEC_FOLDER}/04-implementation-summary.md` with your observations about whether the tests align with what was implemented, any interface assumptions in the tests that differ from reality, and any concerns."

     b. **`qa-engineer` in IMPLEMENTATION mode (cross-review)**:
     - Prompt: "You are completing a cross-review. Read the Software Engineer's implementation summary at `{SPEC_FOLDER}/04-implementation-summary.md`. Then read your own test report at `{SPEC_FOLDER}/04-test-report.md`. Append a '## Cross-Review Notes' section to your document at `{SPEC_FOLDER}/04-test-report.md` with your observations about whether the implementation matches what the tests assume, any deviations from plan that affect test correctness, and any concerns."

     c. **`software-architect` in IMPLEMENTATION mode (cross-review)** (only if activated):
     - Prompt: "You are completing a cross-review. Read the DevOps Engineer's infrastructure summary at `{SPEC_FOLDER}/04-infra-summary.md`. Then read your own implementation summary at `{SPEC_FOLDER}/04-implementation-summary.md`. Append a '## Cross-Review Notes' section to your document at `{SPEC_FOLDER}/04-implementation-summary.md` with your observations about whether the infrastructure implementation aligns with the architecture decisions, any concerns about infra changes that affect application behaviour, and any concerns."

     d. **`devops-engineer` in IMPLEMENTATION mode (cross-review)** (only if activated):
     - Prompt: "You are completing a cross-review. Read the Software Engineer's implementation summary at `{SPEC_FOLDER}/04-implementation-summary.md`. Then read your own infrastructure summary at `{SPEC_FOLDER}/04-infra-summary.md`. Append a '## Cross-Review Notes' section to your document at `{SPEC_FOLDER}/04-infra-summary.md` with your observations about whether the application implementation has any infrastructure implications, any deployment concerns raised by the SE's changes, and any concerns."
  ```
  Step 5 is placed between step 4 ("After all sub-PRs are implemented") and step 6 ("Present results"). SE, QA, SA (conditional), and DevOps (conditional) are all present as sub-items.

---

### AC-4: Phase 4 cross-review prompts match the Discovery/Planning pattern

- **Status**: PASS (for major.md; patch.md and minor.md Phase 4 are absent — see AC-1 and AC-2)
- **Evidence**:
  - All four prompts in major.md Phase 4 step 5 open with `"You are completing a cross-review."`.
  - Each prompt specifies which document to read first (the peer's document).
  - Each prompt specifies which document to append to (the agent's own document).
  - Each prompt uses the section heading `## Cross-Review Notes`.
  - Document paths use the `{SPEC_FOLDER}/[filename]` pattern with backtick quoting.

  For major.md Phase 1.9 step 3, the same pattern is followed:
  - SA prompt opens with `"You are completing a cross-review."`, reads `01-spec-infra-review.md`, appends `## Cross-Review Notes` to `01-spec-arch-review.md`.
  - DevOps prompt opens with `"You are completing a cross-review."`, reads `01-spec-arch-review.md`, appends `## Cross-Review Notes` to `01-spec-infra-review.md`.

- **Notes**: The patch.md Phase 5 step 3 prompt opens with `"You are completing a final reflection."` rather than `"You are completing a cross-review."` — this is intentional and semantically appropriate for a reflection step, not a first-read cross-review. The spec does not mandate the opening phrase for this step. No deviation.

---

### AC-5: Phase 4 cross-review prompts follow parallel launch pattern

- **Status**: PASS (for major.md; patch.md and minor.md Phase 4 are absent — see AC-1 and AC-2)
- **Evidence**: major.md Phase 4 step 5 is a single numbered step with four lettered sub-items (`a.` through `d.`), matching the parallel launch structure used in Phase 2 step 3 and Phase 3 step 3 of major.md. The step label reads `**Cross-review round** — Launch agents in parallel (2 or 4):`, which is explicit about parallelism.

  major.md Phase 1.9 step 3 is a single numbered step with two lettered sub-items (`a.` SA, `b.` DevOps), labelled `**Cross-review round** — Launch two agents in parallel:`. Both agents launch together, not sequentially.

---

### AC-6: Phase 5 patch QA final reflection step is added

- **Status**: PASS
- **Evidence**: Reading `workflows/patch.md` Phase 5 (`## Phase 5: Quality Gates`, lines 141–178):
  - Step 1: `**Launch \`qa-engineer\` in QUALITY GATE mode**`
  - Step 2: `**After QA completes, launch \`software-engineer\` in QUALITY GATE mode**`
  - Step 3: `**After SE completes, launch \`qa-engineer\` in QUALITY GATE mode (final reflection)**:` (new step)
    - Prompt: `"You are completing a final reflection. Read the full quality gate report at \`{SPEC_FOLDER}/05-quality-gate.md\`, including the Software Engineer's '## Software Engineer - Test Quality Review' section. Append a '## QA Engineer - Final Reflection' section to \`{SPEC_FOLDER}/05-quality-gate.md\` acknowledging the SE's test quality findings, noting any updates to your assessment warranted by the SE's observations, and confirming or revising your overall verdict."`
  - Step 4: `**Read the quality gate report.**` (renumbered from 3)
  - Step 5: `**Present results to the user**` (renumbered from 4)
  - Step 6: `**Handle the verdict**` (renumbered from 5)

  The step is positioned after the SE review (step 2) and uses explicit sequential language ("After SE completes"). The heading `## QA Engineer - Final Reflection` matches the spec exactly. Former steps 3, 4, 5 are correctly renumbered to 4, 5, 6 with no gaps.

---

### AC-7: Phase 1.7/1.9 SA↔DevOps cross-review exists in major.md (when DevOps is active)

- **Status**: PASS
- **Evidence**: Reading `workflows/major.md` Phase 1.9 `### Steps (only if activated):` block (lines 91–106):
  - Step 1: `**Launch \`devops-engineer\` in SPEC REVIEW mode**`
  - Step 2: `**Read the infra spec review**. Present to user combined with Phase 1.7 results if both present. **User checkpoint**.`
  - Step 3: `**Cross-review round** — Launch two agents in parallel:`
    - Sub-item `a.`: SA in SPEC REVIEW mode (cross-review) — reads `01-spec-infra-review.md`, appends `## Cross-Review Notes` to `01-spec-arch-review.md`
    - Sub-item `b.`: DevOps in SPEC REVIEW mode (cross-review) — reads `01-spec-arch-review.md`, appends `## Cross-Review Notes` to `01-spec-infra-review.md`

  Both agents are launched in parallel within the conditional block. SA reads DevOps's document; DevOps reads SA's document. Each appends `## Cross-Review Notes` to their own document, as specified.

- **Notes**: The `**Track activation status**` paragraph immediately follows step 3 as unnumbered prose, preserving its original position and format.

---

### AC-8: Phase 1.7/1.9 cross-review is skipped when DevOps is not active

- **Status**: PASS
- **Evidence**: The new step 3 is physically located inside the `### Steps (only if activated):` block of Phase 1.9. The `### Activation Check:` block immediately above this section (lines 87–89) gates the entire `### Steps (only if activated):` section: "If empty/'None'/'N/A' → SKIP. Otherwise → ACTIVATE." When DevOps is not activated, the orchestrator skips all steps in this block, including the new step 3. No separate unconditional SA↔DevOps cross-review block was added outside this conditional section — confirmed by reading from Phase 1.9 to the Phase 2 heading: only the `**Track activation status**` paragraph and a `---` separator appear between step 3 and the Phase 2 heading.

---

### AC-9: Workflow document structure remains consistent

- **Status**: PASS (for implemented steps in major.md and patch.md Phase 5; not verifiable for missing AC-1/AC-2 steps)
- **Evidence**:
  - major.md new steps use em-dash (`—`) in step labels: `**Cross-review round** — Launch two agents in parallel:` and `**Cross-review round** — Launch agents in parallel (2 or 4):`, matching the existing major.md style (e.g., Phase 2 step 3: `**Cross-review round** — Launch agents in parallel (3-5):`).
  - Agent sub-item format uses backtick-quoted agent names and `(cross-review)` parenthetical: `**\`software-architect\` in SPEC REVIEW mode (cross-review)**:`, consistent with existing patterns.
  - patch.md Phase 5 step 3 is a standalone numbered step (not a parallel sub-item), matching the format of adjacent steps 1 and 2. It uses the prefix "After SE completes" to signal sequential dependency, consistent with step 2's use of "After QA completes".
  - The SA/DevOps cross-review sub-items in major.md Phase 4 carry the `(only if activated)` label, matching the pattern used for conditional agents in Phase 2 and Phase 3 (e.g., `**\`devops-engineer\` cross-review** (only if activated):`).

---

### AC-10: No existing workflow steps are removed or reordered

- **Status**: PASS (for the implemented changes; not applicable to AC-1/AC-2 which are absent)
- **Evidence**:
  - **patch.md Phase 5**: Original steps 1 and 2 are intact and unaltered. Former steps 3, 4, 5 are renumbered to 4, 5, 6 with their original content preserved. The new step 3 is a pure addition.
  - **patch.md Phase 2 and Phase 3**: Cross-review steps read intact. Phase 6 reads intact.
  - **major.md Phase 1.9**: Original steps 1 and 2 are intact and at their original numbers. The `**Track activation status**` paragraph remains unnumbered. New step 3 is a pure addition.
  - **major.md Phase 4**: Original steps 1–4 are intact. Former steps 5 and 6 are renumbered to 6 and 7 with their content preserved. New step 5 is a pure addition.
  - **major.md Phase 2 and Phase 3**: Cross-review steps read intact. Phase 6 reads intact.
  - **minor.md**: No changes were made to minor.md in PR 2, and all Phase 2, Phase 3, and Phase 6 steps read intact.

---

## Code Quality Assessment

- **Convention compliance**: The implemented changes (major.md Phase 1.9 step 3, major.md Phase 4 step 5, patch.md Phase 5 step 3) follow existing formatting conventions precisely — em-dash in major.md, backtick-quoted agent names, `(only if activated)` labels, and the `{SPEC_FOLDER}/` path prefix pattern.
- **Readability**: The new steps are clear, self-contained, and follow the same prose style as existing prompts. Prompt text is appropriately concise and actionable.
- **Error handling**: Not applicable — workflow markdown files have no runtime error handling.
- **No scope creep**: The implemented changes stay within spec scope. No extra steps or modifications were made beyond what the spec requires. However, AC-1 and AC-2 (patch.md and minor.md Phase 4 cross-reviews) are absent, indicating the scope was not fully completed.

---

## Test Coverage Assessment

- **Criteria coverage**: 8 of 10 acceptance criteria have been verified as present in the live files. AC-1 and AC-2 are verified as absent.
- **Edge case coverage**: The test report (PR 2) covered all edge cases within its stated scope — conditionality of Phase 1.9 cross-review, correct document references, `Track activation status` preservation, and non-Phase-4 document references not crossing into Phase 4 steps.
- **Regression coverage**: All checked regression items pass. Phase 2, Phase 3, and Phase 6 steps are unmodified in all three workflow files. The SE test quality review step (patch.md Phase 5 step 2) is unchanged.

---

## Regression Risk

- **Risk level**: low
- **Rationale**: The changes that were implemented are additive insertions only. No existing steps were deleted or reworded. Step renumbering was applied correctly in both affected files. The absent AC-1 and AC-2 changes represent missing additions, not regressions — the existing patch.md and minor.md Phase 4 sections remain exactly as they were before this spec, so no orchestrator behavior degrades.
- **Areas to monitor**: After AC-1 and AC-2 are implemented, verify that the new cross-review step in patch.md Phase 4 does not conflict with the pre-existing Phase 5 step numbering (Phase 5 already has a renumbered step 3 added by AC-6 — that renumbering is based on Phase 5's own numbering, not Phase 4's, so no conflict is expected).

---

## Blockers

1. **AC-1 not implemented — Phase 4 cross-review absent from patch.md**: The live file `workflows/patch.md` Phase 4 contains no cross-review step between steps 4 and 5. The spec requires a parallel SE↔QA cross-review round at this position. This is a required acceptance criterion for the spec and must be present before the spec can be considered complete.

2. **AC-2 not implemented — Phase 4 cross-review absent from minor.md**: The live file `workflows/minor.md` Phase 4 contains no cross-review step between steps 4 and 5. The spec requires a parallel SE↔QA cross-review round at this position. This is a required acceptance criterion for the spec and must be present before the spec can be considered complete.

---

## Recommendations

1. **Verify PR 1 delivery**: The implementation summary and test report state that AC-1 and AC-2 were implemented in a separate "PR 1 session." The live workflow files do not reflect this. Before implementing again, confirm whether PR 1 was committed and pushed, or whether the files in the working directory are from before PR 1 was applied. If PR 1 is on a separate branch that has not been merged, the missing changes may exist there and simply need to be merged.

2. **Future PR scope clarity**: When a single spec is delivered across multiple PRs in separate sessions, the quality gate should be deferred until all PRs are complete and all changes are present in the target branch. Running a quality gate against only the PR 2 branch without PR 1 merged creates the risk seen here — partial coverage of the spec that passes the test report but fails the quality gate.

---

## Verdict

### Decision: REJECTED

**Rationale**: Two of ten acceptance criteria — AC-1 (Phase 4 cross-review in patch.md) and AC-2 (Phase 4 cross-review in minor.md) — are not present in the live workflow files. Both criteria are core deliverables defined in the spec scope. The quality gate cannot approve a spec whose primary gap-closing objective is partially unaddressed in the delivered files. The eight implemented criteria (AC-3 through AC-10) are all correctly implemented and of high quality; the rejection is solely due to the two missing Phase 4 cross-review insertions.

**Required fixes**:
1. Add a Phase 4 parallel SE↔QA cross-review step to `workflows/patch.md` between the existing steps 4 and 5, following the same prompt pattern used in major.md Phase 4 step 5a and 5b and in the existing Phase 2 and Phase 3 cross-review steps in patch.md.
2. Add a Phase 4 parallel SE↔QA cross-review step to `workflows/minor.md` between the existing steps 4 and 5 (the "After all sub-PRs are implemented" consolidation step and "Read both output documents"), following the same prompt pattern and em-dash formatting style used in minor.md Phase 2 and Phase 3 cross-review steps.
